Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This study will assess the safety and efficacy of ARQ-252 cream in combination with NB-UVB phototherapy treatment in individuals with non-segmental facial vitiligo.
Epistemonikos ID: 5e3eaa648888164ca20e2af6c29cf27ce82d44fa
First added on: May 08, 2024